Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study

Abstract The decision to use voriconazole for suspected COVID-19-associated pulmonary aspergillosis (CAPA) is based on clinical judgement weighed against concerns about its potential toxicity. We assessed the safety profile of voriconazole for patients with suspected CAPA by conducting a retrospecti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medical mycology (Oxford) 2023-06, Vol.61 (6)
Hauptverfasser:	Costa-Pinto, Rahul, Klink, Sarah, Rotherham, Hannah, Perera, Padeepa, Finlay, Liam, Urbancic, Karen, Vaz, Karl, Trubiano, Jason, Bellomo, Rinaldo
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!